Dynavax Technologies | Crediti Commerciali



Trade Debtors Cambiamento Data
AbbVie USD 12.48B 1.56B 2025-03
Adma Biologics USD 50M 141K 2024-12
Amgen USD 8.7B 569M 2025-06
AstraZeneca USD 16.24B 1.42B 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Dynavax Technologies USD 73.34M 16.79M 2025-06
Gilead Sciences USD 4.78B 393M 2025-06
Glaxosmithkline GBP 7.32B 542M 2024-12
Merck USD 12.72B 1.14B 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Pfizer USD 16.09B 1.35B 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
TG Therapeutics USD 231.52M 102.33M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Dynavax Technologies Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.